Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This is a two arm, double-blind randomized study looking at the effect of zoledronate, a
bisphosphonate, on the bone mineral density (BMD) of postmenopausal women with breast cancer.